| scholarly article | Q13442814 |
| P2093 | author name string | Mostafa Rezaie-Tavirani | |
| Roya Faraji Darkhaneh | |||
| Hakimeh Zali | |||
| Haniyeh Bashi Zadeh Fakhar | |||
| Babak Babaabasi | |||
| P2860 | cites work | Cytoscape: a software environment for integrated models of biomolecular interaction networks | Q24515682 |
| Potential of apoptotic pathway-targeted cancer therapeutic research: Where do we stand? | Q26771601 | ||
| The molecular fingerprint of high grade serous ovarian cancer reflects its fallopian tube origin | Q27008375 | ||
| Integrated genomic analyses of ovarian carcinoma | Q27860518 | ||
| Cancer statistics, 2013 | Q27860762 | ||
| Acute-phase proteins and other systemic responses to inflammation | Q28296941 | ||
| Oncoproteomic analysis reveals co-upregulation of RELA and STAT5 in carboplatin resistant ovarian carcinoma | Q28474516 | ||
| Mediators of endoplasmic reticulum stress-induced apoptosis | Q29615496 | ||
| Comparative proteomic analysis of advanced serous epithelial ovarian carcinoma: possible predictors of chemoresistant disease. | Q30155842 | ||
| Proteomic-based identification of haptoglobin-1 precursor as a novel circulating biomarker of ovarian cancer | Q30763413 | ||
| 2D differential in-gel electrophoresis for the identification of esophageal scans cell cancer-specific protein markers | Q31092484 | ||
| Characterization of serum biomarkers for detection of early stage ovarian cancer | Q33225572 | ||
| A candidate precursor to serous carcinoma that originates in the distal fallopian tube. | Q33264156 | ||
| Three new potential ovarian cancer biomarkers detected in human urine with equalizer bead technology | Q33386060 | ||
| Quantitative proteomics analysis integrated with microarray data reveals that extracellular matrix proteins, catenins, and p53 binding protein 1 are important for chemotherapy response in ovarian cancers. | Q33440799 | ||
| Association of the actin-binding protein transgelin with lymph node metastasis in human colorectal cancer | Q33499383 | ||
| Keratin 5 overexpression is associated with serous ovarian cancer recurrence and chemotherapy resistance. | Q33566693 | ||
| The biology of ovarian cancer: new opportunities for translation | Q33622369 | ||
| MALDI imaging mass spectrometry in ovarian cancer for tracking, identifying, and validating biomarkers. | Q33645334 | ||
| Cancer survival in Australia, Canada, Denmark, Norway, Sweden, and the UK, 1995-2007 (the International Cancer Benchmarking Partnership): an analysis of population-based cancer registry data | Q33779753 | ||
| Platelet-derived thrombospondin-1 is a critical negative regulator and potential biomarker of angiogenesis | Q33896683 | ||
| Haptoglobin: function and polymorphism. | Q33927500 | ||
| A novel proteomic biomarker panel as a diagnostic tool for patients with ovarian cancer | Q33998256 | ||
| Role of autophagy in cancer: management of metabolic stress | Q33999458 | ||
| Increasing melanoma cell death using inhibitors of protein disulfide isomerases to abrogate survival responses to endoplasmic reticulum stress. | Q34051194 | ||
| Ovarian cancer development and metastasis | Q34086819 | ||
| Generation and regulation of human CD4+ IL-17-producing T cells in ovarian cancer | Q34843832 | ||
| Glutathione peroxidase 3 is a candidate mechanism of anticancer drug resistance of ovarian clear cell adenocarcinoma | Q34884588 | ||
| Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer--shifting the paradigm | Q35140600 | ||
| Angiotensin induction of PAI-1 expression in endothelial cells is mediated by the hexapeptide angiotensin IV | Q35766872 | ||
| Transgelin increases metastatic potential of colorectal cancer cells in vivo and alters expression of genes involved in cell motility | Q35915024 | ||
| Exclusion from spheroid formation identifies loss of essential cell-cell adhesion molecules in colon cancer cells. | Q48215330 | ||
| Validation of serum biomarkers for detection of early-stage ovarian cancer. | Q51769706 | ||
| GSTP1-1 in ovarian cyst fluid and disease outcome of patients with ovarian cancer. | Q53189627 | ||
| SM22alpha: the novel phenotype marker of injured glomerular epithelial cells in anti-glomerular basement membrane nephritis. | Q53551193 | ||
| Detection of circulating tumor cells in peripheral blood of patients with metastatic breast cancer: a validation study of the CellSearch system. | Q55043149 | ||
| Targeting HER-2/neu in early breast cancer development using dendritic cells with staged interleukin-12 burst secretion. | Q55043174 | ||
| Metabolomic serum profiling detects early-stage high-grade serous ovarian cancer in a mouse model | Q57146844 | ||
| FIGO Cancer Report 2018 | Q57298793 | ||
| The prognostic values of the peroxiredoxins family in ovarian cancer | Q58763914 | ||
| Overexpression and cytoplasmic localization of caspase-6 is associated with lamin A degradation in set of ovarian cancers | Q59137546 | ||
| Protein expression patterns associated with advanced stage ovarian cancer | Q61855549 | ||
| Coexistence of intracytoplasmic lumens and membrane-bound vesicles in an invasive carcinoma arising in a cystosarcoma phyllodes | Q69850890 | ||
| Biosynthesis, intracellular processing and secretion of haptoglobin in cultured rat hepatocytes | Q71819483 | ||
| Regulation of telomerase by alternate splicing of human telomerase reverse transcriptase (hTERT) in normal and neoplastic ovary, endometrium and myometrium | Q73396764 | ||
| Ovarian cancer | Q82238526 | ||
| Prognostic value of CA 125 in ovarian cyst fluid of patients with epithelial ovarian cancer | Q82372290 | ||
| Significance of early changes in the serum CA-125 antigen level on overall survival in advanced ovarian cancer | Q83087790 | ||
| Proteomic characterization of ovarian cancers identifying annexin-A4, phosphoserine aminotransferase, cellular retinoic acid-binding protein 2, and serpin B5 as histology-specific biomarkers | Q83414403 | ||
| Crude and age-specific incidence rate patterns for histopathologic subtypes of ovarian cancer in Iran | Q84139036 | ||
| Maintenance therapy for ovarian cancer: of Helsinki and Hippocrates | Q84459003 | ||
| Serum haptoglobin in patients with ovarian malignancies | Q93832184 | ||
| Primary extraosseous Ewing sarcoma of the lung in children | Q36791086 | ||
| Potential tumor biomarkers identified in ovarian cyst fluid by quantitative proteomic analysis, iTRAQ. | Q36797835 | ||
| Prognostic factors in early-stage ovarian cancer | Q36922815 | ||
| High resistance to cisplatin in human ovarian cancer cell lines is associated with marked increase of glutathione synthesis | Q36936167 | ||
| The tumor suppressor gene ARHI regulates autophagy and tumor dormancy in human ovarian cancer cells | Q36972761 | ||
| The multifunctional protein glyceraldehyde-3-phosphate dehydrogenase is both regulated and controls colony-stimulating factor-1 messenger RNA stability in ovarian cancer | Q36982940 | ||
| Detection, clinical relevance and specific biological properties of disseminating tumour cells | Q37135356 | ||
| Role of iron in carcinogenesis: cancer as a ferrotoxic disease | Q37329184 | ||
| Depletion of dendritic cells delays ovarian cancer progression by boosting antitumor immunity. | Q37342848 | ||
| Targeting the telosome: therapeutic implications | Q37472298 | ||
| Epithelial-mesenchymal transition in ovarian cancer. | Q37625486 | ||
| Biomolecular pathogenesis of borderline ovarian tumors: focusing target discovery through proteogenomics. | Q37678504 | ||
| Contribution of platelets to tumour metastasis. | Q37831798 | ||
| A review of current proteomics technologies with a survey on their widespread use in reproductive biology investigations. | Q37983163 | ||
| Transgelins, cytoskeletal proteins implicated in different aspects of cancer development | Q38183143 | ||
| Protein-protein interaction network analysis of cirrhosis liver disease | Q38448298 | ||
| QuickGO: a web-based tool for Gene Ontology searching | Q38509056 | ||
| MicroRNA-224: as a potential target for miR-based therapy of cancer | Q38562796 | ||
| E2F1 induces miR-224/452 expression to drive EMT through TXNIP downregulation | Q38945520 | ||
| Deregulated expression of miR-224 and its target gene: CD59 predicts outcome of diffuse large B-cell lymphoma patients treated with R-CHOP. | Q38963893 | ||
| Network-based analysis of differentially expressed genes in cerebrospinal fluid (CSF) and blood reveals new candidate genes for multiple sclerosis. | Q39061447 | ||
| Transcriptional cooperation between p53 and NF-κB p65 regulates microRNA-224 transcription in mouse ovarian granulosa cells. | Q39183106 | ||
| Changes in keratin expression during metastatic progression of breast cancer: impact on the detection of circulating tumor cells | Q39415341 | ||
| High resolution ArrayCGH and expression profiling identifies PTPRD and PCDH17/PCH68 as tumor suppressor gene candidates in laryngeal squamous cell carcinoma. | Q39611034 | ||
| Transgelin is a direct target of TGF-beta/Smad3-dependent epithelial cell migration in lung fibrosis | Q40017400 | ||
| Transfection of Smac/DIABLO sensitizes drug-resistant tumor cells to TRAIL or paclitaxel-induced apoptosis in vitro | Q40047160 | ||
| Differential protein expression profiling by iTRAQ-2DLC-MS/MS of lung cancer cells undergoing epithelial-mesenchymal transition reveals a migratory/invasive phenotype | Q40283971 | ||
| Increased expression of peroxiredoxin II confers resistance to cisplatin | Q40800516 | ||
| Epithelial-mesenchymal transformation of a newly established cell line from ovarian adenosarcoma by transforming growth factor-beta1. | Q41213529 | ||
| Independent component analysis uncovers the landscape of the bladder tumor transcriptome and reveals insights into luminal and basal subtypes | Q41747556 | ||
| A framework for personalized medicine: prediction of drug sensitivity in cancer by proteomic profiling | Q41810419 | ||
| An introduction to effective use of enrichment analysis software | Q42007533 | ||
| There are multiple forms of glyceraldehyde-3-phosphate dehydrogenase in prostate cancer cells and normal prostate tissue | Q42518466 | ||
| Immunophenotyping of serous carcinoma of the female genital tract | Q43997124 | ||
| "Primary peritoneal" high-grade serous carcinoma is very likely metastatic from serous tubal intraepithelial carcinoma: assessing the new paradigm of ovarian and pelvic serous carcinogenesis and its implications for screening for ovarian cancer | Q44049813 | ||
| HE4 and mesothelin: novel biomarkers of ovarian carcinoma in patients with pelvic masses. | Q46715694 | ||
| Apolipoprotein A-I induces IL-10 and PGE2 production in human monocytes and inhibits dendritic cell differentiation and maturation. | Q46783416 | ||
| The use of multiple novel tumor biomarkers for the detection of ovarian carcinoma in patients with a pelvic mass. | Q46864787 | ||
| High-grade ovarian serous carcinoma patients exhibit profound alterations in lipid metabolism | Q47150076 | ||
| Tumor cytosol dipeptidyl peptidase III activity is increased with histological aggressiveness of ovarian primary carcinomas | Q47582771 | ||
| Diagnostic accuracy of haptoglobin within ovarian cyst fluid as a potential point-of-care test for epithelial ovarian cancer: an observational study | Q47867514 | ||
| P4510 | describes a project that uses | Cytoscape | Q3699942 |
| P433 | issue | 1 | |
| P921 | main subject | ovarian cancer | Q172341 |
| P304 | page(s) | 64 | |
| P577 | publication date | 2019-07-17 | |
| P1433 | published in | Journal of Ovarian Research | Q27721898 |
| P1476 | title | Proteome profiling of low grade serous ovarian cancer | |
| P478 | volume | 12 |
Search more.